Evaluation of the effectiveness of Boswellia serrata in the treatment of psoriasis

Phase 3

Conditions: Psoriasis vulgaris.
Psoriasis vulgaris
L40.0

Registration Number: IRCT20150721023282N23

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 22

Inclusion Criteria

Mild psoriasis vulgaris in the areas of limbs and trunk; Mild psoriasis is defined as Involvement of a maximum of 10% of the body surface area (BSA).

Exclusion Criteria

Incidence of other types of psoriasis (erythrodermic, guttate, ...)
Incidence of Facial or scalp psoriasis
Incidence of psoriatic arthritis
Receiving systemic anti-psoriasis treatment and phototherapy during last month
Receiving topical anti-psoriasis treatment during last two weeks
Autoimmune disorders
Incidence of other chronic skin disorders (pemphigus, eczema, dermatitis, lichen planus)
Infection in the lesion
Pregnancy
Lactation

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in Psoriasis Area and Severity Index (PASI) Before the intervention and at the end of the intervention. Timepoint: Before the intervention, 28 days after the start of intervention. Method of measurement: The online calculator that is available on the following website: https://www.mdcalc.com/calc/10182/psoriasis-area-severity-index-pasi.;Percentage change in body surface area (BSA) at the end of the intervention. Timepoint: Before the intervention, 28 days after the start of intervention. Method of measurement: chart.

Secondary Outcome Measures

Name	Time	Method
Intensity of itching. Timepoint: Before the intervention, 28 days after the start of intervention. Method of measurement: Use Visual Analogue Scale (VAS) from 0 (No itchy) to 10 (Extremely itchy) by patients.;Proportion of people with PASI 50 (decrease of at least 50% in the PASI score) at the end of the intervention. Timepoint: Before the intervention, 28 days after the start of intervention. Method of measurement: Observation.;Proportion of people with complete recovery (PASI 90) at the end of the intervention. Timepoint: Before the intervention, 28 days after the start of intervention. Method of measurement: Observation.